Microcirculatory Dysfunction in Sepsis

Critical Care Nursing Clinics of North America

Volumn 23, Issue 1, 2011, Pages 67-77

  Lundy, David J ^a   Trzeciak, Stephen ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Microcirculation; Organ failure; Sepsis; Septic shock; Severe sepsis

Indexed keywords

NITRIC OXIDE;

BLOOD VESSEL; CRITICAL ILLNESS; ENDOTHELIUM; HUMAN; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; VASCULARIZATION;

BLOOD VESSELS; CRITICAL ILLNESS; ENDOTHELIUM; HUMANS; MICROCIRCULATION; NITRIC OXIDE; SEPSIS;

EID: 79751503702     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2010.12.004     Document Type: Review

References (104)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
2. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348(2):138-150.
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
4. Lin S.M., Huang C.D., Lin H.C., et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 2006, 26(6):551-557.
5. Jones A.E., Brown M.D., Trzeciak S., et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med 2008, 36(10):2734-2739.
6. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006, 130(5):1579-1595.
7. Ellis C.G., Bateman R.M., Sharpe M.D., et al. Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol Heart Circ Physiol 2002, 282(1):H156-H164.
8. Farquhar I., Martin C.M., Lam C., et al. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996, 61(1):190-196.
9. Fries M., Weil M.H., Sun S., et al. Increases in tissue Pco2 during circulatory shock reflect selective decreases in capillary blood flow. Crit Care Med 2006, 34(2):446-452.
10. Lam C., Tyml K., Martin C., et al. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994, 94(5):2077-2083.
11. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166(1):98-104.
12. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32(9):1825-1831.
13. Aird W.C. Endothelium as an organ system. Crit Care Med 2004, 32(5 Suppl):s271-s279.
14. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327(6122):524-526.
15. Tyml K., Wang X., Lidington D., et al. Lipopolysaccharide reduces intercellular coupling in vitro and arteriolar conducted response in vivo. Am J Physiol Heart Circ Physiol 2001, 281(3):H1397-H1406.
16. Aird W.C. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001, 29(7 Suppl):s28-s34. [discussion: s34-5].
17. Yan S.B., Helterbrand J.D., Hartman D.L., et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001, 120(3):915-922.
18. Terada L.S., Hybertson B.M., Connelly K.G., et al. XO increases neutrophil adherence to endothelial cells by a dual ICAM-1 and P-selectin-mediated mechanism. J Appl Physiol 1997, 82(3):866-873.
19. Shapiro N.I., Yano K., Okada H., et al. A prospective, observational study of soluble Flt-1 and vascular endothelial growth factor in sepsis. Shock 2008, 29(4):452-457.
20. Yano K., Liaw P.C., Mullington J.M., et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006, 203(6):1447-1458.
21. Bateman R.M., Jagger J.E., Sharpe M.D., et al. Erythrocyte deformability is a nitric oxide-mediated factor in decreased capillary density during sepsis. Am J Physiol Heart Circ Physiol 2001, 280(6):H2848-H2856.
22. Condon M.R., Kim J.E., Deitch E.A., et al. Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis. Am J Physiol Heart Circ Physiol 2003, 284(6):H2177-H2184.
23. Kempe D.S., Akel A., Lang P.A., et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007, 85(3):273-281.
24. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101(10):3765-3777.
25. Azuma H., Ishikawa M., Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986, 88(2):411-415.
26. Cambien B., Bergmeier W., Saffaripour S., et al. Antithrombotic activity of TNF-alpha. J Clin Invest 2003, 112(10):1589-1596.
27. Hutcheson I.R., Whittle B.J., Boughton-Smith N.K. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990, 101(4):815-820.
28. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991, 88(11):4651-4655.
29. Mendelsohn M.E., O'Neill S., George D., et al. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 1990, 265(31):19028-19034.
30. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987, 2(8567):1057-1058.
31. Radomski M.W., Vallance P., Whitley G., et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993, 27(7):1380-1382.
32. Shultz P.J., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992, 90(5):1718-1725.
33. Cunha F.Q., Assreuy J., Moss D.W., et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 1994, 81(2):211-215.
34. Morin M.J., Unno N., Hodin R.A., et al. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 1998, 26(7):1258-1264.
35. Ince C., Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999, 27(7):1369-1377.
36. Trzeciak S., Dellinger R.P., Parrillo J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007, 49(1):88-98. 98, e1-2.
37. Doerschug K.C., Delsing A.S., Schmidt G.A., et al. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007, 293(2):H1065-H1071.
38. Vincent J.L., De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005, 9(Suppl 4):s9-s12.
39. Levy M.M., Macias W.L., Vincent J.L., et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005, 33(10):2194-2201.
40. Shapiro N., Howell M.D., Bates D.W., et al. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006, 48(5):583-590. 590, e1.
41. Trzeciak S., McCoy J.V., Phillip Dellinger R., et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008, 34(12):2210-2217.
42. Goedhart P.T., Khalilzada M., Bezemer R., et al. Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 2007, 15:15101-15114.
43. Groner W., Winkelman J.W., Harris A.G., et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 1999, 5(10):1209-1212.
44. Harris A.G., Sinitsina I., Messmer K. The Cytoscan Model E-II, a new reflectance microscope for intravital microscopy: comparison with the standard fluorescence method. J Vasc Res 2000, 37(6):469-476.
45. Mathura K.R., Vollebregt K.C., Boer K., et al. Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Physiol 2001, 91(1):74-78.
46. Mazzarelli J., Guglielmi M., Ross F., et al. Leukocyte dynamics measured by orthogonal polarization spectral imaging correlate with video microscopy. Shock 2005, 23(Suppl 3):122. [abstract].
47. Creteur J., De Backer D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 2006, 32(4):516-523.
48. Marik P.E. Sublingual capnography: a clinical validation study. Chest 2001, 120(3):923-927.
49. Nakagawa Y., Weil M.H., Tang W., et al. Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1838-1843.
50. Weil M.H., Nakagawa Y., Tang W., et al. Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 1999, 27(7):1225-1229.
51. Jin X., Weil M.H., Sun S., et al. Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock. J Appl Physiol 1998, 85(6):2360-2364.
52. Povoas H.P., Weil M.H., Tang W., et al. Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest 2000, 118(4):1127-1132.
53. Povoas H.P., Weil M.H., Tang W., et al. Decreases in mesenteric blood flow associated with increases in sublingual PCO2 during hemorrhagic shock. Shock 2001, 15(5):398-402.
54. De Backer D., Creteur J., Noordally O., et al. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients?. Am J Respir Crit Care Med 1998, 157(4 Pt 1):1219-1225.
55. Guzman J.A., Lacoma F.J., Kruse J.A. Relationship between systemic oxygen supply dependency and gastric intramucosal PCO2 during progressive hemorrhage. J Trauma 1998, 44(4):696-700.
56. Nelson D.P., Beyer C., Samsel R.W., et al. Pathological supply dependence of O2 uptake during bacteremia in dogs. J Appl Physiol 1987, 63(4):1487-1492.
57. Boerma E.C., Van der Voort P.H., Spronk P.E., et al. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 2007, 35(4):1055-1060.
58. De Backer D., Hollenberg S., Boerma C., et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007, 11(5):R101.
59. Bihari D., Smithies M., Gimson A., et al. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987, 317(7):397-403.
60. Shoemaker W.C., Appel P.L., Kram H.B., et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988, 94(6):1176-1186.
61. De Backer D., Creteur J., Dubois M.J., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006, 34(2):403-408.
62. De Backer D., Verdant C., Chierego M., et al. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34(7):1918-1924.
63. Hoffmann J.N., Vollmar B., Laschke M.W., et al. Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition. Crit Care 2005, 9(Suppl 4):s33-s37.
64. Iba T., Kidokoro A., Fukunaga M., et al. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 2005, 33(2):368-372.
65. Baker C.H., Wilmoth F.R. Microvascular responses to E. coli endotoxin with altered adrenergic activity. Circ Shock 1984, 12(3):165-176.
66. Hollenberg S.M., Broussard M., Osman J., et al. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000, 86(7):774-778.
67. Hollenberg S.M., Tangora J.J., Piotrowski M.J., et al. Impaired microvascular vasoconstrictive responses to vasopressin in septic rats. Crit Care Med 1997, 25(5):869-873.
68. Price S.A., Spain D.A., Wilson M.A., et al. Subacute sepsis impairs vascular smooth muscle contractile machinery and alters vasoconstrictor and dilator mechanisms. J Surg Res 1999, 83(1):75-80.
69. Bakker J., Grover R., McLuckie A., et al. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004, 32(1):1-12.
70. Hollenberg S.M., Cunnion R.E., Zimmerberg J. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993, 264(2 Pt 2):H660-H663.
71. Hollenberg S.M., Easington C.R., Osman J., et al. Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 1999, 12(4):262-267.
72. Hollenberg S.M., Piotrowski M.J., Parrillo J.E. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 1997, 272(3 Pt 2):R969-R974.
73. Watson D., Grover R., Anzueto A., et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004, 32(1):13-20.
74. Anning P.B., Sair M., Winlove C.P., et al. Abnormal tissue oxygenation and cardiovascular changes in endotoxemia. Am J Respir Crit Care Med 1999, 159(6):1710-1715.
75. Avontuur J.A., Bruining H.A., Ince C. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995, 76(3):418-425.
76. Corso C.O., Gundersen Y., Dorger M., et al. Effects of the nitric oxide synthase inhibitors N(G)-nitro-l-arginine methyl ester and aminoethyl-isothiourea on the liver microcirculation in rat endotoxemia. J Hepatol 1998, 28(1):61-69.
77. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Am J Physiol 1992, 262(2 Pt 2):H611-H615.
78. Nishida J., McCuskey R.S., McDonnell D., et al. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994, 267(6 Pt 1):G1135-G1141.
79. Spain D.A., Wilson M.A., Bar-Natan M.F., et al. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 1994, 36(5):720-725.
80. Spain D.A., Wilson M.A., Bloom I.T., et al. Renal microvascular responses to sepsis are dependent on nitric oxide. J Surg Res 1994, 56(6):524-529.
81. Spain D.A., Wilson M.A., Garrison R.N. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994, 116(2):322-330. [discussion: 330-1].
82. Tribl B., Bateman R.M., Milkovich S., et al. Effect of nitric oxide on capillary hemodynamics and cell injury in the pancreas during Pseudomonas pneumonia-induced sepsis. Am J Physiol Heart Circ Physiol 2004, 286(1):H340-H345.
83. Binion D.G., Fu S., Ramanujam K.S., et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 1998, 275(3 Pt 1):G592-G603.
84. Sundrani R., Easington C.R., Mattoo A., et al. Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Crit Care Med 2000, 28(8):2898-2903.
85. Hickey M.J., Granger D.N., Kubes P. Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand 2001, 173(1):119-126.
86. Hickey M.J., Sharkey K.A., Sihota E.G., et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997, 11(12):955-964.
87. Lush C.W., Cepinskas G., Sibbald W.J., et al. Endothelial E- and P-selectin expression in iNOS-deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastrointest Liver Physiol 2001, 280(2):G291-G297.
88. Dellinger R.P., Parrillo J.E. Mediator modulation therapy of severe sepsis and septic shock: does it work?. Crit Care Med 2004, 32(1):282-286.
89. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32(1):21-30.
90. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96(1):60-68.
91. Boughton-Smith N.K., Hutcheson I.R., Deakin A.M., et al. Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol 1990, 191(3):485-488.
92. Gundersen Y., Corso C.O., Leiderer R., et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 1998, 24(12):1257-1263.
93. Siegemund M., van Bommel J., Vollebrecht K., et al. Influence of nitric oxide donor SIN-1 on the gut oxygenation in a normodynamic, porcine model of low-dose endotoxemia. Intensive Care Med 2000, 26:S362. [abstract].
94. Zhang H., Rogiers P., Smail N., et al. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock. J Appl Physiol 1997, 83(4):1164-1173.
95. Spronk P.E., Ince C., Gardien M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002, 360(9343):1395-1396.
96. Spronk P., Ince C., Gardien M., et al. Nitroglycerin for septic shock. Lancet 2003, 361(9360):880.
97. Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis (NCT00608322) Available at:, National Library of Medicine, Bethesda. Accessed May, 2009. http://www.ClinicalTrials.gov.
98. The Effect of Nitroglycerine on Microcirculatory Abnormalities During Sepsis (NCT00493415) Available at:, National Library of Medicine, Bethesda. Accessed May, 2009. http://www.ClinicalTrials.gov.
99. Abraham E., Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007, 35(10):2408-2416.
100. Cinel I., Dellinger R.P. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007, 20(4):345-352.
101. Fink M.P. Bench-to-bedside review: cytopathic hypoxia. Crit Care 2002, 6(6):491-499.
102. Hotchkiss R.S., Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992, 267(11):1503-1510.
103. Watts J.A., Kline J.A. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med 2003, 10(9):985-997.
104. Singer M., De Santis V., Vitale D., et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364(9433):545-548.